Synthesis of N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3-H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as potential dual inhibitor DHFR and TS.

被引：0
|
作者：
Gangjee, A
Lin, X
McGuire, JJ
Kisliuk, RL
机构：
[1] Duquesne Univ, Sch Pharmaceut Chem, Div Med Chem, Pittsburgh, PA 15282 USA
[2] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Buffalo, NY USA
[3] Tufts Univ, Sch Med, Dept Biochem, Medford, MA 02155 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
135-MEDI
引用
收藏
页码：U198 / U198
页数：1
相关论文
共 50 条
  • [41] Synthesis, crystal structure and DFT study of a novel compound N-(4-(2,4-dimorpholinopyrido[2,3-d]pyrimidin-6-yl)phenyl)pyrrolidine-1-carboxamide
    Zhou, Zhixu
    Liu, Ye
    Ren, Qian
    Yu, Dehou
    Lu, Hongguang
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1235
  • [42] SYNTHESIS AND ANTITUMOR ACTIVITIES OF NOVEL 6-5 FUSED-RING HETEROCYCLE ANTIFOLATES - N-[4-[OMEGA-(2-AMINO-4-SUBSTITUTED-6,7-DIHYDROCYCLOPENTA[D]PYRIMIDIN-5-YL)ALKYL]BENZOYL]-L-GLUTAMIC ACIDS
    KOTAKE, Y
    IIJIMA, A
    YOSHIMATSU, K
    TAMAI, N
    OZAWA, Y
    KOYANAGI, N
    KITOH, K
    NOMURA, H
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (11) : 1616 - 1624
  • [43] A Facile Synthesis and Docking Studies of N-(3-(4-Chlorophenoxy)benzyl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
    Bommera, Ravi Kumar
    Merugu, Ramchander
    Eppakayala, Laxminarayana
    CHEMICAL METHODOLOGIES, 2019, 3 (03): : 360 - 367
  • [44] PHASE-I STUDIES WITH CB3717 (N-(4-(N-AMINO-4-HYDROXY-6-QUINAZOLINLY)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID)
    CALVERT, AH
    ALISON, DL
    HARLAND, SJ
    JACKMAN, AL
    MOONEY, CJ
    SMITH, IE
    HARRAP, KR
    BRITISH JOURNAL OF CANCER, 1983, 48 (01) : 116 - 117
  • [45] PHASE-I CLINICAL-TRIAL OF CB3717 ((N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID)
    ALISON, DL
    MOONEY, C
    ROBINSON, B
    SMITH, IE
    WILTSHAW, E
    MCELWAIN, TJ
    CALVERT, AH
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 107 - 107
  • [46] Synthesis and Biological Evaluation of N-[4-(2-trans-[([2,6-Diamino-4( 3H)- oxopyrimidin-5-yl]methyl)thio]cyclobutyl)benzoyl$R B@-L glutamic acid a Novel 5-Thiapymidinone Inhibitor of Dihydrofolate Reductase
    Varney, M. D.
    Romines, W. H.
    Boritzki, T.
    Margosiak, S. A.
    Journal of Heterocyclic Chemistry,
  • [47] Three-component reaction for synthesis of2-amino-6-aryl-5-(phenylamino)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one derivatives in water
    Yang, Xiaopeng
    Li, Chunmei
    Qi, Chenze
    Zhang, Furen
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (09) : 3271 - 3278
  • [48] BIOCHEMICAL EFFECTS OF A QUINAZOLINE INHIBITOR OF THYMIDYLATE SYNTHETASE, N-(4-(N-((2-AMINO-4-HYDROXY-6-QUINAZOLINYL)METHYL)PROP-2-YNYLAMINO)BENZOYL)-L-GLUTAMIC ACID (CB3717), ON HUMAN-LYMPHOBLASTOID CELLS
    JACKSON, RC
    JACKMAN, AL
    CALVERT, AH
    BIOCHEMICAL PHARMACOLOGY, 1983, 32 (24) : 3783 - 3790
  • [49] Correlation of antibacterial activity of some N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno[2,3-d]pyrimidin-4-ones with topological indices using Hansch analysis
    Narasimhan, Balasubramanian
    Kumari, Meena
    Jain, Nitin
    Dhake, Avinash
    Sundaravelan, Chandrasekaran
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4951 - 4958
  • [50] Synthesis and biological evaluation of N-{4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl)benzoyl}-L-glutamic acid as a potential inhibitor of GAR Tfase and the de novo purine biosynthetic pathway
    Cheng, H
    Hwang, I
    Chong, YH
    Tavassoli, A
    Webb, ME
    Zhang, Y
    Wilson, IA
    Benkovic, SJ
    Boger, DL
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (10) : 3593 - 3599
12345